"Neutropenia" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A decrease in the number of NEUTROPHILS found in the blood.
| Descriptor ID |
D009503
|
| MeSH Number(s) |
C15.378.553.546.184.564
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Neutropenia".
Below are MeSH descriptors whose meaning is more specific than "Neutropenia".
This graph shows the total number of publications written about "Neutropenia" by people in this website by year, and whether "Neutropenia" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2013 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2018 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Neutropenia" by people in Profiles.
-
Lymphopenia and neutropenia are associated with subsequent incident proteinuria in Danish patients with systemic lupus erythematosus. Scand J Rheumatol. 2020 Mar; 49(2):122-130.
-
Association of Preoperative Cell Counts With Outcomes After Operation for Congenital Heart Disease. Ann Thorac Surg. 2018 10; 106(4):1234-1240.
-
History of chronic comorbidity and risk of chemotherapy-induced febrile neutropenia in cancer patients not receiving G-CSF prophylaxis. Ann Oncol. 2014 Sep; 25(9):1821-9.
-
Risk and consequences of chemotherapy-induced neutropenic complications in patients receiving daily filgrastim: the importance of duration of prophylaxis. BMC Health Serv Res. 2014 Apr 27; 14:189.
-
Chronic comorbid conditions associated with risk of febrile neutropenia in breast cancer patients treated with chemotherapy. Breast Cancer Res Treat. 2013 Apr; 138(2):621-31.
-
Technical evaluation of methods for identifying chemotherapy-induced febrile neutropenia in healthcare claims databases. BMC Health Serv Res. 2013 Feb 13; 13:60.
-
Cost of neutropenic complications of chemotherapy. Ann Oncol. 2008 Mar; 19(3):454-60.
-
Are shorter courses of filgrastim prophylaxis associated with increased risk of hospitalization? Ann Pharmacother. 2006 Mar; 40(3):402-7.
-
Ambulatory management of chemotherapy-induced fever and neutropenia in adult cancer patients. Ann Pharmacother. 1998 Dec; 32(12):1317-23.
-
The efficacy of recombinant human granulocyte colony-stimulating factor and recombinant human granulocyte macrophage colony-stimulating factor in permitting the administration of higher doses of cyclophosphamide in a doxorubicin-cyclophosphamide combination. An NSABP pilot study in patients with metastatic or high-risk primary breast cancer. National Surgical Adjuvant Breast and Bowel Project. Am J Clin Oncol. 1994 Oct; 17(5):374-81; discussion 382.